Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AVANOS MEDICAL, INC. | 12,003 | reported | 08 May 2026 | tx 2+24,006 |
| ALNYLAM PHARMACEUTICALS, INC. | 4,320 | reported | 28 Feb 2024 | tx 23+64,016−18,323 |
| ALEXION PHARMACEUTICALS INC | 0 | reported | 21 Jul 2021 | tx 27+186,392−186,392 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 May 2026 | GRANT_AWARD | AVANOS MEDICAL, INC. | 12,003 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | AVANOS MEDICAL, INC. | 12,003 | 0.00 USD | |
| 28 Feb 2024 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 9 | 157.30 USD | |
| 28 Feb 2024 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1 | 158.09 USD | |
| 27 Feb 2024 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 878 | 0.00 USD | |
| 28 Feb 2024 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 142 | 154.54 USD | |
| 28 Feb 2024 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 111 | 155.45 USD | |
| 28 Feb 2024 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 66 | 156.38 USD | |
| 27 Feb 2024 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 878 | 0.00 USD | deriv |
| 01 Feb 2024 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5,175 | 0.00 USD | |
| 02 Feb 2024 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 502 | 170.01 USD | |
| 02 Feb 2024 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 820 | 171.14 USD | |
| 02 Feb 2024 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 269 | 172.38 USD | |
| 01 Feb 2024 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5,175 | 0.00 USD | deriv |
| 06 Apr 2023 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 3,500 | 210.00 USD | |
| 27 Feb 2023 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 2,632 | 0.00 USD | deriv |
| 27 Feb 2023 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 5,449 | 0.00 USD | deriv |
| 02 Feb 2023 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 586 | 226.62 USD | |
| 02 Feb 2023 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,007 | 225.80 USD | |
| 02 Feb 2023 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 77 | 223.97 USD | |
| 01 Feb 2023 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5,175 | 0.00 USD | |
| 02 Feb 2023 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 5 | 227.38 USD | |
| 01 Feb 2023 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5,175 | 0.00 USD | deriv |
| 01 Feb 2022 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 29,182 | 0.00 USD | deriv |
| 01 Feb 2022 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 15,525 | 0.00 USD | deriv |